SAN FRANCISCO, Aug. 02, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Paragon 28, Inc. (NYSE: FNA) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/FNA Contact the Firm Now: FNA@hbsslaw.com | 844-916-0895 Paragon 28, Inc. (FNA) Investigation: Medical device company Paragon 28 is facing mounting scrutiny over its financial reporting ...

LOS ANGELES, Aug. 1, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE: FNA) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Paragon filed an 8-K with the SEC on July 30, 2024. The filing stated, "On July 3 ...

NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE: FNA). Investors who purchased Paragon 28 securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FNA. Investigation Details On July 30, 2024, Paragon 28 filed a current report on Form 8-K with the SEC, and stated that "On ...

Paragon 28, Inc. (NYSE:FNA) Q1 2024 Earnings Conference Call May 8, 2024 4:30 PM ET Company Participants Matthew Brinckman - Senior Vice President, Strategy and IR Albert DaCosta - Chairman, CEO, Co Founder Krissy Wright - Interim Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler & Co. George Sellers - Stephens Inc. Craig Bijou - BofA Securities Mike Matson - Needham & Company, LLC Justin Lin - William Blair & Company LLC Dave Turkaly - Citizens Financial Group Caitlin Cro ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40902 Paragon 28, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3170186 (State or other jurisdiction of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2024 Paragon 28, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40902 27-3170186 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No .) 14445 Grasslands Drive Englewood, Colorado 80112 (Address of Principal ...

OXFORD, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- OrganOx, a medical device company which is changing the paradigm in liver transplantation in the US and Europe with its groundbreaking normothermic machine perfusion technology, today announces that Stephen (Steve) M. Deitsch will be joining OrganOx as Chief Financial Officer ("CFO") on April 8, 2024. Steve joins OrganOx from Paragon 28 (NYSE:FNA), a leading medical device company exclusively focused on the foot and ankle orthopaedic market, where h ...

Paragon 28, Inc. (FNA) , a leading innovator in orthopedic solutions, has unveiled its latest breakthrough — the Grappler R3INFORCE Extraosseous Repair System.This system is set to advance syndesmotic injury repair, marking significant progress for Paragon 28 in terms of improving patient outcomes.Addressing Syndesmotic InstabilityThe Grappler R3INFORCE System is specifically designed to restore stability to the anterior and posterior ligaments surrounding the ankle during fibula fracture repairs and high a ...

Paragon 28, Inc. (FNA) shares rallied 16.2% in the last trading session to close at $11.91. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 15.7% loss over the past four weeks.Paragon 28 scored a strong price increase, on investors’ optimism driven by the company’s recent announcement of the 2023 fourth-quarter results, wherein the top-line increased 17.6% compared to the last year’s comparable period. Intern ...

| --- | --- | |-------|-------| | | | | | | | | | These forward-looking statements are based on Paragon 28's current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties. These risks and uncertainties are described more fully in the section titled "Risk Factors" in Paragon 28's filings with the Securities and Exchange Commi ...